Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2013

Mar 28, 2013

34117_dirs_2013-03-28_4ec262d5-7d78-4688-ab9c-8701caff31d7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2013-03-28

Reporting Person: Williams Kent B. (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-03-28 Employee Stock Options (Right to Buy) $0.195 A 300000 Acquired 2023-03-28 Common Stock (300000) Direct

Footnotes

F1: On March 28, 2013, the reporting person was granted an option to purchase 300,000 shares of common stock. Options vest and become exercisable in four (4) equal installments on each March 31, 2013, June 30, 2013, September 30, 2013 and December 31, 2013.